| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |